Healthcare provider profile · identity verified

Samina Seraj, MD

Allopathic & Osteopathic Physicians|Internal Medicine · JENKINTOWN, PA · NPI 1720127947

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Samina Seraj, MD received $16.95 in general payments during 2025 across 1 reported records.

Intra-Sana Laboratories accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 3 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$16.95

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Intra-Sana Laboratories	Unresolved — no canonical attribution shown	$16.95	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$16.95	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
GLYCATE Normalized: glycate	Drug	Intra-Sana Laboratories	$16.95	1	2025
Source payment records 2025-01-17 · Intra-Sana Laboratories · $16.95 · Open Payments source
RELTONE 200 MG Normalized: reltone 200 mg	Drug	Intra-Sana Laboratories	$16.95	1	2025
Source payment records 2025-01-17 · Intra-Sana Laboratories · $16.95 · Open Payments source
RELTONE 400 MG Normalized: reltone 400 mg	Drug	Intra-Sana Laboratories	$16.95	1	2025
Source payment records 2025-01-17 · Intra-Sana Laboratories · $16.95 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	672	169
Amlodipine Besylate	Amlodipine Besylate	510	114
Levothyroxine Sodium	Levothyroxine Sodium	340	69
Furosemide	Furosemide	328	68
Gabapentin	Gabapentin	323	66
Losartan Potassium	Losartan Potassium	292	61
Metoprolol Succinate	Metoprolol Succinate	266	55
Pantoprazole Sodium	Pantoprazole Sodium	253	54
Lisinopril	Lisinopril	226	55
Sertraline Hcl	Sertraline Hcl	222	39
Eliquis	Apixaban	207	28
Omeprazole	Omeprazole	175	45
Potassium Chloride	Potassium Chloride	161	42
Simvastatin	Simvastatin	156	31
Tamsulosin Hcl	Tamsulosin Hcl	153	26
Famotidine	Famotidine	150	37
Metformin Hcl	Metformin Hcl	149	34
Metoprolol Tartrate	Metoprolol Tartrate	143	25
Hydrochlorothiazide	Hydrochlorothiazide	130	37
Lorazepam	Lorazepam	125	30
Mirtazapine	Mirtazapine	124	27
Duloxetine Hcl	Duloxetine Hcl	121	21
Tramadol Hcl	Tramadol Hcl	121	26
Rosuvastatin Calcium	Rosuvastatin Calcium	120	39
Hydralazine Hcl	Hydralazine Hcl	117	21
Albuterol Sulfate Hfa	Albuterol Sulfate	113	43
Carvedilol	Carvedilol	111	27
Clopidogrel	Clopidogrel Bisulfate	110	25
Escitalopram Oxalate	Escitalopram Oxalate	107	27
Ezetimibe	Ezetimibe	106	24
Quetiapine Fumarate	Quetiapine Fumarate	102	12
Latanoprost	Latanoprost	96	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	95	18
Allopurinol	Allopurinol	90	21
Donepezil Hcl	Donepezil Hcl	86	14
Alprazolam	Alprazolam	84	21
Trulicity	Dulaglutide	84	suppressed
Memantine Hcl	Memantine Hcl	79	suppressed
Pravastatin Sodium	Pravastatin Sodium	76	12
Atenolol	Atenolol	72	19
Tradjenta	Linagliptin	65	suppressed
Cephalexin	Cephalexin	62	36
Fluticasone Propionate	Fluticasone Propionate	59	28
Oxycodone Hcl	Oxycodone Hcl	57	12
Triamcinolone Acetonide	Triamcinolone Acetonide	56	24
Trazodone Hcl	Trazodone Hcl	55	16
Warfarin Sodium	Warfarin Sodium	55	suppressed
Januvia	Sitagliptin Phosphate	53	suppressed
Nifedipine Er	Nifedipine	53	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	51	16
Citalopram Hbr	Citalopram Hydrobromide	48	suppressed
Insulin Aspart Flexpen	Insulin Aspart	48	suppressed
Xarelto	Rivaroxaban	48	suppressed
Montelukast Sodium	Montelukast Sodium	47	15
Buspirone Hcl	Buspirone Hcl	45	14
Bupropion Xl	Bupropion Hcl	44	11
Carbidopa-Levodopa	Carbidopa/Levodopa	43	suppressed
Diclofenac Sodium	Diclofenac Sodium	42	13
Jardiance	Empagliflozin	41	suppressed
Klor-Con 10	Potassium Chloride	41	suppressed
Valsartan	Valsartan	41	13
Aripiprazole	Aripiprazole	39	suppressed
Spironolactone	Spironolactone	39	11
Cyclosporine	Cyclosporine	37	suppressed
Finasteride	Finasteride	37	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	36	14
Baclofen	Baclofen	35	suppressed
Amoxicillin	Amoxicillin	34	16
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	33	suppressed
Repaglinide	Repaglinide	33	suppressed
Azithromycin	Azithromycin	32	26
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	32	suppressed
Brilinta	Ticagrelor	31	suppressed
Bumetanide	Bumetanide	31	suppressed
Metolazone	Metolazone	31	suppressed
Ramipril	Ramipril	31	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	31	suppressed
Alendronate Sodium	Alendronate Sodium	29	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Meloxicam	Meloxicam	28	11
Lantus	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Propranolol Hcl	Propranolol Hcl	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	26	suppressed
Chlorthalidone	Chlorthalidone	26	suppressed
Ondansetron Hcl	Ondansetron Hcl	26	20
Pregabalin	Pregabalin	26	suppressed
Amiodarone Hcl	Amiodarone Hcl	25	suppressed
Synthroid	Levothyroxine Sodium	25	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	14
Benazepril Hcl	Benazepril Hcl	23	suppressed
Divalproex Sodium	Divalproex Sodium	23	suppressed
Galantamine Er	Galantamine Hbr	23	suppressed
Metformin Hcl Er	Metformin Hcl	23	11
Methimazole	Methimazole	23	suppressed
Methylprednisolone	Methylprednisolone	23	17
Nystatin	Nystatin	23	15
Prednisone	Prednisone	23	19
Brimonidine Tartrate	Brimonidine Tartrate	22	suppressed
Glipizide Er	Glipizide	22	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	22	suppressed
Restasis	Cyclosporine	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	suppressed
Clonidine Hcl	Clonidine Hcl	21	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Humalog Kwikpen U-100	Insulin Lispro	21	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	21	14
Meclizine Hcl	Meclizine Hcl	21	suppressed
Entresto	Sacubitril/Valsartan	20	suppressed
Niacin Er	Niacin	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Clonazepam	Clonazepam	19	suppressed
Glimepiride	Glimepiride	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Digoxin	Digoxin	18	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	18	suppressed
Nebivolol Hcl	Nebivolol Hcl	18	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	18	15
Torsemide	Torsemide	18	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	13
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	17	suppressed
Glipizide	Glipizide	17	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	17	suppressed
Mupirocin	Mupirocin	17	15
Myrbetriq	Mirabegron	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	16	suppressed
Diltiazem Hcl	Diltiazem Hcl	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Morphine Sulfate	Morphine Sulfate	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Tyrvaya	Varenicline Tartrate	14	suppressed
Balsalazide Disodium	Balsalazide Disodium	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	12	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Methadone Hcl	Methadone Hcl	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Ammonium Lactate	Ammonium Lactate	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Pentoxifylline	Pentoxifylline	11	suppressed
Propafenone Hcl	Propafenone Hcl	11	suppressed
Saxagliptin Hcl	Saxagliptin Hcl	11	suppressed
Trandolapril	Trandolapril	11	suppressed
Trospium Chloride Er	Trospium Chloride	11	suppressed
Xtampza Er	Oxycodone Myristate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$16.95 · 1 records	Intra-Sana Laboratories	GLYCATE, RELTONE 200 MG, RELTONE 400 MG	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error